What does CUSIP 71880W204 represent in this 13F holders report?

CUSIP 71880W204 is the security identifier for PHIO - PHIO PHARMACEUTICALS CORP - COM used to aggregate holder disclosures.

How many institutions held PHIO - PHIO PHARMACEUTICALS CORP - COM in Q1 2019?

12 institutional investors reported PHIO - PHIO PHARMACEUTICALS CORP - COM for Q1 2019. Use the holders table for investor-level position and value details.

PHIO PHARMACEUTICALS CORP - COM (PHIO)

CUSIP: 71880W204

Q1 2019 13F Holders as of 31 Mar 2019

Security type / class: Equity / COM
Total 13F shares: 1,313,293
Total 13F value: $591,002
Share change: -643,588
SEC-reported price per share: $0.45
Number of holders: 12
Value change: -$100,123
Number of buys: 9
Number of sells: 2

Security key

71880W204

Report period

Q1 2019

Institutions

Top holders

PHIO full security history Ownership snapshot Full 13F holder table Phio Pharmaceuticals Corp. SEC filings Phio Pharmaceuticals Corp. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of PHIO - PHIO PHARMACEUTICALS CORP - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

SABBY MANAGEMENT, LLC

Disclosed value leader

SABBY MANAGEMENT, LLC

Comparable rows

0/7

Latest evidence

31 Dec 2018

13F Highest disclosed value: $520,000 7 rows are not safely comparable across share classes. Showing 1-6 of 7 holder rows.

Quick read

SABBY MANAGEMENT, LLC has the largest disclosed position value at $520K.

0 of 7 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SABBY MANAGEMENT, LLC's linked filing trail.

Disclosed position value Top 5

SABBY MANAGEMENT, LLC $520K

SG Americas Securities, LLC $54K

CVI Holdings, LLC $51K

VANGUARD GROUP INC $9K

CITADEL ADVISORS LLC $7K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 7 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
SABBY MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$520,000 1,575,157 shares	—	31 Dec 2018
SG Americas Securities, LLC	13F Company 13F	— denominator unverified	$54,000 163,730 shares	—	31 Dec 2018
CVI Holdings, LLC	13F Company 13F	— denominator unverified	$51,000 155,135 shares	—	31 Dec 2018
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$9,000 26,460 shares	—	31 Dec 2018
CITADEL ADVISORS LLC	13F Company 13F	— denominator unverified	$7,000 19,886 shares	—	31 Dec 2018
EDMOND DE ROTHSCHILD HOLDING S.A.	13F Company 13F	— denominator unverified	$4,000 10,790 shares	—	31 Dec 2018

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,313,293

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Holder diff

Investor	Q1 2019 Shares	Q1 2019 Shares	Share Diff	Share Chg %	Q1 2019 value	Q1 2019 value	Value change	Value Chg %